87 related articles for article (PubMed ID: 16120188)
1. Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction.
De Pasquale CG; Arnolda LF; Doyle IR; Aylward PE; Russell AE; Bersten AD
Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):622-7. PubMed ID: 16120188
[TBL] [Abstract][Full Text] [Related]
2. Circulating atrial natriuretic polypeptide during exercise in patients with essential hypertension.
Nishikimi T; Kohno M; Matsuura T; Kanayama Y; Akioka K; Teragaki M; Yasuda M; Oku H; Takeuchi K; Takeda T
J Hypertens Suppl; 1986 Dec; 4(6):S546-9. PubMed ID: 2956390
[TBL] [Abstract][Full Text] [Related]
3. Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema.
De Pasquale CG; Arnolda LF; Doyle IR; Grant RL; Aylward PE; Bersten AD
Crit Care Med; 2003 Apr; 31(4):1060-7. PubMed ID: 12682473
[TBL] [Abstract][Full Text] [Related]
4. N-terminal pro-atrial natriuretic peptide and exercise prescription in patients with myocardial infarction.
Ikeda N; Yasu T; Nishikimi T; Nakamura T; Kubo N; Kawakami M; Momomura S; Saito M
Regul Pept; 2007 Jun; 141(1-3):154-8. PubMed ID: 17292492
[TBL] [Abstract][Full Text] [Related]
5. Regulation of coronary blood flow during exercise.
Duncker DJ; Bache RJ
Physiol Rev; 2008 Jul; 88(3):1009-86. PubMed ID: 18626066
[TBL] [Abstract][Full Text] [Related]
6. Correlation between left ventricular mass and the resting and post-exercise release of ANP in healthy men.
Pawlicki L; Irzmański R; Rózalski S; Kowalski J; Kokot F
Med Sci Monit; 2001; 7(5):903-7. PubMed ID: 11535932
[TBL] [Abstract][Full Text] [Related]
7. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation.
Wozakowska-Kapłon B; Opolski G
Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231
[TBL] [Abstract][Full Text] [Related]
8. Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure.
Magrì D; Brioschi M; Banfi C; Schmid JP; Palermo P; Contini M; Apostolo A; Bussotti M; Tremoli E; Sciomer S; Cattadori G; Fiorentini C; Agostoni P
Circ Heart Fail; 2009 May; 2(3):175-80. PubMed ID: 19808337
[TBL] [Abstract][Full Text] [Related]
9. Beta-erythropoietin effects on ventricular remodeling, left and right systolic function, pulmonary pressure, and hospitalizations in patients affected with heart failure and anemia.
Palazzuoli A; Silverberg DS; Calabrò A; Spinelli T; Quatrini I; Campagna MS; Franci B; Nuti R
J Cardiovasc Pharmacol; 2009 Jun; 53(6):462-7. PubMed ID: 19455052
[TBL] [Abstract][Full Text] [Related]
10. High-sensitivity C-reactive protein and parameters of left ventricular dysfunction.
Shah SJ; Marcus GM; Gerber IL; McKeown BH; Vessey JC; Jordan MV; Huddleston M; Foster E; Chatterjee K; Michaels AD
J Card Fail; 2006 Feb; 12(1):61-5. PubMed ID: 16500582
[TBL] [Abstract][Full Text] [Related]
11. Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.
Engelmann MD; Niemann L; Kanstrup IL; Skagen K; Godtfredsen J
Int J Cardiol; 2005 Oct; 105(1):31-9. PubMed ID: 16207542
[TBL] [Abstract][Full Text] [Related]
12. Diastolic dysfunction and abnormalities of the microcirculation in type 2 diabetes.
Brooks BA; Franjic B; Ban CR; Swaraj K; Yue DK; Celermajer DS; Twigg SM
Diabetes Obes Metab; 2008 Sep; 10(9):739-46. PubMed ID: 17941867
[TBL] [Abstract][Full Text] [Related]
13. B-type natriuretic peptide levels in patients with COPD and normal right ventricular function.
Gemici G; Erdim R; Celiker A; Tokay S; Ones T; Inanir S; Oktay A
Adv Ther; 2008 Jul; 25(7):674-80. PubMed ID: 18563310
[TBL] [Abstract][Full Text] [Related]
14. Effect of physical exercise training on health-related quality of life and exercise tolerance in patients with left ventricular dysfunction.
Toda G; Shibata S; Nakamizo R; Seto S; Yano K
J Cardiol; 2004 Nov; 44(5):179-87. PubMed ID: 15584249
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular abnormal response during dynamic exercise in patients with heart failure and preserved left ventricular ejection fraction at rest.
Ennezat PV; Lefetz Y; Maréchaux S; Six-Carpentier M; Deklunder G; Montaigne D; Bauchart JJ; Mounier-Véhier C; Jude B; Nevière R; Bauters C; Asseman P; de Groote P; Lejemtel TH
J Card Fail; 2008 Aug; 14(6):475-80. PubMed ID: 18672195
[TBL] [Abstract][Full Text] [Related]
16. [Influence of the treatment of the nodal reentrant tachycardia by RF catheter ablation on selected hemodynamic parameters of left ventricular systolic and diastolic function and exercise capacity].
Lelakowski J; Dreher A
Pol Merkur Lekarski; 2009 Jun; 26(156):600-4. PubMed ID: 19711724
[TBL] [Abstract][Full Text] [Related]
17. B-type natriuretic peptide infusions in acute myocardial infarction.
Hillock RJ; Frampton CM; Yandle TG; Troughton RW; Lainchbury JG; Richards AM
Heart; 2008 May; 94(5):617-22. PubMed ID: 17639095
[TBL] [Abstract][Full Text] [Related]
18. Dynamic left ventricular dyssynchrony contributes to B-type natriuretic peptide release during exercise in patients with systolic heart failure.
Lancellotti P; Cosyns B; Piérard LA
Europace; 2008 Apr; 10(4):496-501. PubMed ID: 18319268
[TBL] [Abstract][Full Text] [Related]
19. Recombinant bovine growth hormone-induced reduction of atrial natriuretic peptide is associated with improved left ventricular contractility and reverse remodeling in cardiomyopathic UM-X7.1 hamsters with congestive heart failure.
Mulumba M; Céméus C; Dumont L; du Souich P; Ong H; Marleau S
Growth Horm IGF Res; 2007 Apr; 17(2):96-103. PubMed ID: 17280860
[TBL] [Abstract][Full Text] [Related]
20. Atrial natriuretic peptide behaviour and myocyte hypertrophic profile in combined pressure and volume-induced cardiac hypertrophy.
Cavallero S; González GE; Puyó AM; Rosón MI; Pérez S; Morales C; Hertig CM; Gelpi RJ; Fernández BE
J Hypertens; 2007 Sep; 25(9):1940-50. PubMed ID: 17762660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
